The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.
Host: John E. Anderson, MD Guest: Michael Greenberg, MD Dr. John Anderson joins Dr. Michael Greenberg, host of DermConsult, to discuss skin diseases t...
Host: Carol Wysham, MD Guest: Kristen Nadeau, MD, MS Is there a link between type 2 diabetes and obesity? Dr. Carol Wysham joins Dr. Kristen Nadeau, a...
Guest: Carol Wysham, MD ReachMD host Dr. Carol Wysham discusses what we currently know about hypoglycemia and cardiovascular disease, how to identify ...
Guest: David M. Simpson, MD Guest: Jon T. Gertken, MD Guest: Stephanie Simon, NP Find the full Prescribing Information here. There are multiple ways t...
Host: John E. Anderson, MD Guest: Raghu Mirmira, MD,PhD When treating type 1 diabetes, should we be focusing on disease prevention rather than reversa...
Guest: Kevan C. Herold, MD Guest: Chantal Mathieu, MD, PhD Experts in the immunopathology of type 1 diabetes discuss the epidemiology, non-genetic and...
Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exa...
Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exa...
Host: John Buse, MD, PhD Guest: Anne Louise Peters, MD SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to rece...
Host: John Buse, MD, PhD How early should we start screening for diabetes, and what tools are available to us? In recognition of Diabetes Alert Day, D...